Latent membrane protein 1 (LMP1) of Epstein–Barr virus (EBV) is an integral membrane
protein which has transforming potential and is necessary but not sufficient for B‐cell …

Motivation: Extracellular vesicles (EVs) are spherical bilayered proteolipids, harboring
various bioactive molecules. Due to the complexity of the vesicular nomenclatures and …

Mammalian cells release different types of vesicles, collectively termed extracellular vesicles
(EVs). EVs contain cellular microRNAs (miRNAs) with an apparent potential to deliver their …

With current techniques, genetic alterations of herpesviruses are difficult to perform, mostly
because of the large size of their genomes. To solve this problem, we have designed a …

Epithelial cell adhesion molecule (EpCAM) is a membrane glycoprotein expressed on
adenomatous and simple epithelia, where it is involved in homophilic adhesion at the basolateral …

Latent membrane protein 1 (LMP1) acts like a permanently activated receptor of the tumor
necrosis factor (TNF)‐receptor superfamily and is absolutely required for B cell …

Bispecific Abs (bsAb) are promising immunological tools for the elimination of tumor cells in
minimal residual disease situations. In principle, they target an Ag on tumor cells and recruit …

Virally infected cells degrade intracellular viral proteins proteolytically and present the resulting
peptides in association with major histocompatibility complex (MHC) class I molecules to …

Lifelong persistence of Epstein-Barr virus (EBV) in infected hosts is mainly owed to the virus'
pronounced abilities to evade immune responses of its human host. Active immune evasion …

Reliable detection of disseminated tumor cells and of the biodistribution of tumor-targeting
therapeutic antibodies within the entire body has long been needed to better understand and …